NDC 0781-3391 – Eribulin Mesylate

Eribulin Mesylate .5 mg/mL · Injection · Intravenous

Human Prescription Drug

Product NDC0781-3391

Product details

Brand name
Eribulin Mesylate
Generic name
Eribulin mesylate
Labeler
Sandoz Inc
Dosage form
Injection
Route
Intravenous
Marketing category
ANDA · ANDA214310
Marketed since
July 7, 2025
Listing expires
December 31, 2026
Pharmacologic class
Microtubule Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Eribulin Mesylate →

Package NDC codes (1)

Package NDCDescriptionSince
0781-3391-941 VIAL in 1 CARTON (0781-3391-94) / 2 mL in 1 VIALJul 7, 2025

Other Eribulin Mesylate products